Mapping the patent landscape of synthetic biology for fine chemical production pathways

Pablo Carbonell, Abdullah Gök, Philip Shapira, Jean-Loup Faulon

Research output: Contribution to journalArticle

6 Citations (Scopus)
10 Downloads (Pure)

Abstract

A goal of synthetic biology bio-foundries is to innovate through an iterative design/build/test/learn pipeline. In assessing the value of new chemical production routes, the intellectual property (IP) novelty of the pathway is important. Exploratory studies can be carried using knowledge of the patent/IP landscape for synthetic biology and metabolic engineering. In this paper, we perform an assessment of pathways as potential targets for chemical production across the full catalogue of reachable chemicals in the extended metabolic space of chassis organisms, as computed by the retrosynthesis-based algorithm RetroPath. Our database for reactions processed by sequences in heterologous pathways was screened against the PatSeq database, a comprehensive collection of more than 150M sequences present in patent grants and applications. We also examine related patent families using Derwent Innovations. This large-scale computational study provides useful insights into the IP landscape of synthetic biology for fine and specialty chemicals production.
Original languageEnglish
Pages (from-to)687-695
Number of pages9
JournalMicrobial Biotechnology
Volume9
Issue number5
Early online date3 Aug 2016
DOIs
Publication statusPublished - 30 Sep 2016

Fingerprint

Intellectual property
Metabolic engineering
Chassis
Foundries
Pipelines
Innovation
Synthetic Biology

Keywords

  • synthetic biology
  • intellectual property

Cite this

Carbonell, Pablo ; Gök, Abdullah ; Shapira, Philip ; Faulon, Jean-Loup. / Mapping the patent landscape of synthetic biology for fine chemical production pathways. In: Microbial Biotechnology. 2016 ; Vol. 9, No. 5. pp. 687-695.
@article{1f45a8017cda489ab13f810d9f633f4a,
title = "Mapping the patent landscape of synthetic biology for fine chemical production pathways",
abstract = "A goal of synthetic biology bio-foundries is to innovate through an iterative design/build/test/learn pipeline. In assessing the value of new chemical production routes, the intellectual property (IP) novelty of the pathway is important. Exploratory studies can be carried using knowledge of the patent/IP landscape for synthetic biology and metabolic engineering. In this paper, we perform an assessment of pathways as potential targets for chemical production across the full catalogue of reachable chemicals in the extended metabolic space of chassis organisms, as computed by the retrosynthesis-based algorithm RetroPath. Our database for reactions processed by sequences in heterologous pathways was screened against the PatSeq database, a comprehensive collection of more than 150M sequences present in patent grants and applications. We also examine related patent families using Derwent Innovations. This large-scale computational study provides useful insights into the IP landscape of synthetic biology for fine and specialty chemicals production.",
keywords = "synthetic biology, intellectual property",
author = "Pablo Carbonell and Abdullah G{\"o}k and Philip Shapira and Jean-Loup Faulon",
note = "The authors acknowledge funding from the BBSRC under grant BB/M017702/1, ‘Centre for Synthetic Biology of Fine and Speciality Chemicals’. JLF would like to acknowledge funding provided by the ANR grant ANR-15-CE1-0008.",
year = "2016",
month = "9",
day = "30",
doi = "10.1111/1751-7915.12401",
language = "English",
volume = "9",
pages = "687--695",
journal = "Microbial Biotechnology",
issn = "1751-7907",
number = "5",

}

Mapping the patent landscape of synthetic biology for fine chemical production pathways. / Carbonell, Pablo; Gök, Abdullah; Shapira, Philip; Faulon, Jean-Loup.

In: Microbial Biotechnology, Vol. 9, No. 5, 30.09.2016, p. 687-695.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Mapping the patent landscape of synthetic biology for fine chemical production pathways

AU - Carbonell, Pablo

AU - Gök, Abdullah

AU - Shapira, Philip

AU - Faulon, Jean-Loup

N1 - The authors acknowledge funding from the BBSRC under grant BB/M017702/1, ‘Centre for Synthetic Biology of Fine and Speciality Chemicals’. JLF would like to acknowledge funding provided by the ANR grant ANR-15-CE1-0008.

PY - 2016/9/30

Y1 - 2016/9/30

N2 - A goal of synthetic biology bio-foundries is to innovate through an iterative design/build/test/learn pipeline. In assessing the value of new chemical production routes, the intellectual property (IP) novelty of the pathway is important. Exploratory studies can be carried using knowledge of the patent/IP landscape for synthetic biology and metabolic engineering. In this paper, we perform an assessment of pathways as potential targets for chemical production across the full catalogue of reachable chemicals in the extended metabolic space of chassis organisms, as computed by the retrosynthesis-based algorithm RetroPath. Our database for reactions processed by sequences in heterologous pathways was screened against the PatSeq database, a comprehensive collection of more than 150M sequences present in patent grants and applications. We also examine related patent families using Derwent Innovations. This large-scale computational study provides useful insights into the IP landscape of synthetic biology for fine and specialty chemicals production.

AB - A goal of synthetic biology bio-foundries is to innovate through an iterative design/build/test/learn pipeline. In assessing the value of new chemical production routes, the intellectual property (IP) novelty of the pathway is important. Exploratory studies can be carried using knowledge of the patent/IP landscape for synthetic biology and metabolic engineering. In this paper, we perform an assessment of pathways as potential targets for chemical production across the full catalogue of reachable chemicals in the extended metabolic space of chassis organisms, as computed by the retrosynthesis-based algorithm RetroPath. Our database for reactions processed by sequences in heterologous pathways was screened against the PatSeq database, a comprehensive collection of more than 150M sequences present in patent grants and applications. We also examine related patent families using Derwent Innovations. This large-scale computational study provides useful insights into the IP landscape of synthetic biology for fine and specialty chemicals production.

KW - synthetic biology

KW - intellectual property

U2 - 10.1111/1751-7915.12401

DO - 10.1111/1751-7915.12401

M3 - Article

VL - 9

SP - 687

EP - 695

JO - Microbial Biotechnology

JF - Microbial Biotechnology

SN - 1751-7907

IS - 5

ER -